Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 35

1.

Exploring Gaps of Family History Documentation in EHR for Precision Medicine -A Case Study of Familial Hypercholesterolemia Ascertainment.

Mehrabi S, Wang Y, Ihrke D, Liu H.

AMIA Jt Summits Transl Sci Proc. 2016 Jul 20;2016:160-6. eCollection 2016 Jul 20.

2.

Maternal obesity programs mitochondrial and lipid metabolism gene expression in infant umbilical vein endothelial cells.

Costa SM, Isganaitis E, Matthews TJ, Hughes K, Daher G, Dreyfuss JM, da Silva GA, Patti ME.

Int J Obes (Lond). 2016 Nov;40(11):1627-1634. doi: 10.1038/ijo.2016.142. Epub 2016 Aug 17.

3.

Long-Term Risk of Atherosclerotic Cardiovascular Disease in US Adults With the Familial Hypercholesterolemia Phenotype.

Perak AM, Ning H, de Ferranti SD, Gooding HC, Wilkins JT, Lloyd-Jones DM.

Circulation. 2016 Jul 5;134(1):9-19. doi: 10.1161/CIRCULATIONAHA.116.022335.

PMID:
27358432
4.

Genome-Wide DNA Methylation Analysis and Epigenetic Variations Associated with Congenital Aortic Valve Stenosis (AVS).

Radhakrishna U, Albayrak S, Alpay-Savasan Z, Zeb A, Turkoglu O, Sobolewski P, Bahado-Singh RO.

PLoS One. 2016 May 6;11(5):e0154010. doi: 10.1371/journal.pone.0154010. eCollection 2016 May 6.

5.

Successful Direct Adsorption of Lipoproteins (DALI) Apheresis During Pregnancy in an Omani Woman with Homozygous Familial Hypercholesterolemia.

Al-Dughaishi T, Al-Waili K, Banerjee Y, Sheik S, Al-Sabti H, Al-Zakwani I, Al-Mukhaini S, Al Wahaibi K, Al-Hinai AT, Al-Rasadi K.

Open Cardiovasc Med J. 2015 Dec 29;9:114-7. doi: 10.2174/1874192401509010114. eCollection 2015 Dec 29.

6.

Mendelian randomization to assess causal effects of blood lipids on coronary heart disease: lessons from the past and applications to the future.

Burgess S, Harshfield E.

Curr Opin Endocrinol Diabetes Obes. 2016 Apr;23(2):124-30. doi: 10.1097/MED.0000000000000230. Review.

7.

Squamous cell carcinoma developing in a long-standing case of tuberous xanthoma: An incident unreported hitherto.

Sancheti K, Das A, Podder I, Mohanty S, Gharami RC, Jash PK.

Indian Dermatol Online J. 2015 Dec;6(Suppl 1):S5-8. doi: 10.4103/2229-5178.171053.

8.

Statins: Cholesterol guidelines and Indian perspective.

Menon AS, Kotwal N, Singh Y, Girish R.

Indian J Endocrinol Metab. 2015 Sep-Oct;19(5):546-53. doi: 10.4103/2230-8210.163105. Review.

9.

The association of APOC4 polymorphisms with premature coronary artery disease in a Chinese Han population.

Xu S, Cheng J, Li NH, Chen YN, Cai MY, Tang SS, Huang H, Zhang B, Cen JM, Yang XL, Chen C, Liu X, Xiong XD.

Lipids Health Dis. 2015 Jun 28;14:63. doi: 10.1186/s12944-015-0065-7.

10.

A rare variant in MCF2L identified using exclusion linkage in a pedigree with premature atherosclerosis.

Maiwald S, Motazacker MM, van Capelleveen JC, Sivapalaratnam S, van der Wal AC, van der Loos C, Kastelein JJ, Ouwehand WH, Hovingh GK, Trip MD, van Buul JD, Dallinga-Thie GM.

Eur J Hum Genet. 2016 Jan;24(1):86-91. doi: 10.1038/ejhg.2015.70. Epub 2015 Apr 22.

11.

Association of peripheral arterial and cardiovascular diseases in familial hypercholesterolemia.

Pereira C, Miname M, Makdisse M, Kalil Filho R, Santos RD.

Arq Bras Cardiol. 2014 Aug;103(2):118-23. Epub 2014 Jul 15. English, Portuguese.

12.

MicroRNA-management of lipoprotein homeostasis.

Sun X, Feinberg MW.

Circ Res. 2014 Jun 20;115(1):2-6. doi: 10.1161/CIRCRESAHA.114.304228. No abstract available.

13.

The LRP6 rs2302685 polymorphism is associated with increased risk of myocardial infarction.

Xu S, Cheng J, Chen YN, Li K, Ma ZW, Cen JM, Liu X, Yang XL, Chen C, Xiong XD.

Lipids Health Dis. 2014 Jun 7;13:94. doi: 10.1186/1476-511X-13-94.

14.

Familial hypercholesterolemia impairs exercise-induced systemic vasodilation due to reduced NO bioavailability.

de Beer VJ, Merkus D, Bender SB, Tharp DL, Bowles DK, Duncker DJ, Laughlin MH.

J Appl Physiol (1985). 2013 Dec;115(12):1767-76. doi: 10.1152/japplphysiol.00619.2013. Epub 2013 Oct 24.

15.

Familial hypercholesterolemia and the atherosclerotic disease.

Kim YR, Han KH.

Korean Circ J. 2013 Jun;43(6):363-7. doi: 10.4070/kcj.2013.43.6.363.

16.

Genetic variants from lipid-related pathways and risk for incident myocardial infarction.

Song C, Pedersen NL, Reynolds CA, Sabater-Lleal M, Kanoni S, Willenborg C; CARDIoGRAMplusC4D Consortium., Syvänen AC, Watkins H, Hamsten A, Prince JA, Ingelsson E.

PLoS One. 2013;8(3):e60454. doi: 10.1371/journal.pone.0060454. Epub 2013 Mar 29.

17.

Can multiple lifestyle behaviours be improved in people with familial hypercholesterolemia? Results of a parallel randomised controlled trial.

Broekhuizen K, van Poppel MN, Koppes LL, Kindt I, Brug J, van Mechelen W.

PLoS One. 2012;7(12):e50032. doi: 10.1371/journal.pone.0050032. Epub 2012 Dec 12.

18.

Giant Tuberous Xanthomas in a Case of Type IIA Hypercholesterolemia.

Babu R, Venkataram A, Santhosh S, Shivaswamy S.

J Cutan Aesthet Surg. 2012 Jul;5(3):204-6. doi: 10.4103/0974-2077.101384.

19.

Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci.

Asselbergs FW, Guo Y, van Iperen EP, Sivapalaratnam S, Tragante V, Lanktree MB, Lange LA, Almoguera B, Appelman YE, Barnard J, Baumert J, Beitelshees AL, Bhangale TR, Chen YD, Gaunt TR, Gong Y, Hopewell JC, Johnson T, Kleber ME, Langaee TY, Li M, Li YR, Liu K, McDonough CW, Meijs MF, Middelberg RP, Musunuru K, Nelson CP, O'Connell JR, Padmanabhan S, Pankow JS, Pankratz N, Rafelt S, Rajagopalan R, Romaine SP, Schork NJ, Shaffer J, Shen H, Smith EN, Tischfield SE, van der Most PJ, van Vliet-Ostaptchouk JV, Verweij N, Volcik KA, Zhang L, Bailey KR, Bailey KM, Bauer F, Boer JM, Braund PS, Burt A, Burton PR, Buxbaum SG, Chen W, Cooper-Dehoff RM, Cupples LA, deJong JS, Delles C, Duggan D, Fornage M, Furlong CE, Glazer N, Gums JG, Hastie C, Holmes MV, Illig T, Kirkland SA, Kivimaki M, Klein R, Klein BE, Kooperberg C, Kottke-Marchant K, Kumari M, LaCroix AZ, Mallela L, Murugesan G, Ordovas J, Ouwehand WH, Post WS, Saxena R, Scharnagl H, Schreiner PJ, Shah T, Shields DC, Shimbo D, Srinivasan SR, Stolk RP, Swerdlow DI, Taylor HA Jr, Topol EJ, Toskala E, van Pelt JL, van Setten J, Yusuf S, Whittaker JC, Zwinderman AH; LifeLines Cohort Study., Anand SS, Balmforth AJ, Berenson GS, Bezzina CR, Boehm BO, Boerwinkle E, Casas JP, Caulfield MJ, Clarke R, Connell JM, Cruickshanks KJ, Davidson KW, Day IN, de Bakker PI, Doevendans PA, Dominiczak AF, Hall AS, Hartman CA, Hengstenberg C, Hillege HL, Hofker MH, Humphries SE, Jarvik GP, Johnson JA, Kaess BM, Kathiresan S, Koenig W, Lawlor DA, März W, Melander O, Mitchell BD, Montgomery GW, Munroe PB, Murray SS, Newhouse SJ, Onland-Moret NC, Poulter N, Psaty B, Redline S, Rich SS, Rotter JI, Schunkert H, Sever P, Shuldiner AR, Silverstein RL, Stanton A, Thorand B, Trip MD, Tsai MY, van der Harst P, van der Schoot E, van der Schouw YT, Verschuren WM, Watkins H, Wilde AA, Wolffenbuttel BH, Whitfield JB, Hovingh GK, Ballantyne CM, Wijmenga C, Reilly MP, Martin NG, Wilson JG, Rader DJ, Samani NJ, Reiner AP, Hegele RA, Kastelein JJ, Hingorani AD, Talmud PJ, Hakonarson H, Elbers CC, Keating BJ, Drenos F.

Am J Hum Genet. 2012 Nov 2;91(5):823-38. doi: 10.1016/j.ajhg.2012.08.032. Epub 2012 Oct 11.

20.

Pharmacogenetic aspects in familial hypercholesterolemia with the special focus on FHMarburg (FH p.W556R).

Schaefer JR, Kurt B, Sattler A, Klaus G, Soufi M.

Clin Res Cardiol Suppl. 2012 Jun;7:2-6.

Supplemental Content

Support Center